Symposium Description
5-10% of all cancers can be attributed to inherited gene variants or changes in a particular gene. Cancer can run in families when people have these variants.Genetic testing can help your patients discover that they carry genetic variants - information that will change their lives, especially if they find out before they develop any disease. Potentially life-changing interventions and decisions to protect their health - from undergoing prophylactic procedures to altering family planning schedules - can all be impacted by this vital health information.
Join us for a clinical webinar to learn how women’s health and gender-related health clinicians can play a key role in identifying and screening patients for hereditary cancer risk
This is a 45-minute clinical education webinar followed by a live Q&A session where you will:
- Gain an understanding of hereditary cancer in Women’s Health
- Learn how to identify patients at increased risk for cancer & create more previvors
- Review patient case studies and learn how to address common patient questions
- Learn about the tools and options available to support risk assessment and testing
Vivienne Souter, MD
Speaker Bio
Vivienne Souter is a board-certified Ob/Gyn and Clinical Geneticist and Medical Director in Women’s Health at Natera since 2021. She did her residency training in Genetics at the University of Washington and her Ob/Gyn training at Banner Good Samaritan in Phoenix. She obtained her medical degree (MBChB) and postgraduate research degree (MD) from the University of Glasgow. She is a Fellow of the Royal College of Obstetricians and Gynaecologists and worked in the National Health Service in the UK for more than 10 years before moving to the US. Her interests include genetics and women’s health, quality improvement, predictive modeling, and midwifery care in the USA.
Speaker
Robyn Reese, APRN, CNM
Speaker Bio
Robyn Reese APRN CNM is an advanced practice Registered Nurse and certified nurse midwife in the Tampa Bay Area where she has been in private practice since 2003 after graduating from the University of Florida. Her passion is empowering women to be actively involved in making informed decisions regarding their healthcare. She sees patients from prepubescent and follows patients throughout their lifespan addressing all aspects of their healthcare needs. Robyn advocates for her patients to have genetic testing based on their risk assessment at each office visit and highly encourages patients to have genetic testing and/or counseling when indicated. Educating patients and their families on the benefits of testing and risk reduction has led Robyn to be published in the journal Cureus. 2019, Aug 11(8): e5311 with the publication: The Importance of Risk Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) carriers: A Case Report.